Journal of pharmacokinetics and pharmacodynamics
Apr 16, 2025
The human milk/plasma (M/P) drug concentration ratio is crucial in pharmacology, especially for breastfeeding mothers undergoing treatment. It determines the extent to which drugs ingested by the mother pass into breast milk, potentially affecting th...
Journal of pharmacokinetics and pharmacodynamics
Dec 10, 2024
In randomized, placebo controlled clinical trials (RCT) in major depressive disorders (MDD), treatment response (TR) is estimated by the change from baseline at study-end (EOS) of the scores of clinical scales used for assessing disease severity. Tre...
Journal of pharmacokinetics and pharmacodynamics
Aug 27, 2024
The generation of synthetic patient data that reflect the statistical properties of real data plays a fundamental role in today's world because of its potential to (i) be enable proprietary data access for statistical and research purposes and (ii) i...
Journal of pharmacokinetics and pharmacodynamics
Jun 28, 2024
Forward addition/backward elimination (FABE) has been the standard for population pharmacokinetic model selection (PPK) since NONMEM® was introduced. We investigated five machine learning (ML) algorithms (Genetic algorithm [GA], Gaussian process [GP]...
Journal of pharmacokinetics and pharmacodynamics
Oct 21, 2023
Efficiently finding covariate model structures that minimize the need for random effects to describe pharmacological data is challenging. The standard approach focuses on identification of relevant covariates, and present methodology lacks tools for ...
Journal of pharmacokinetics and pharmacodynamics
Mar 11, 2022
Robust estimation of exposure response analysis relies on correct specification of the model structure with traditional parametric approach. However, the assumptions of the handcrafted model may not always hold or verifiable. Here, we conducted a sim...
Journal of pharmacokinetics and pharmacodynamics
Oct 27, 2021
A fit-for-purpose structural and statistical model is the first major requirement in population pharmacometric model development. In this manuscript we discuss how this complex and computationally intensive task could benefit from supervised machine ...
Journal of pharmacokinetics and pharmacodynamics
May 21, 2021
One of the objectives of Pharmacometry (PMX) population modeling is the identification of significant and clinically relevant relationships between parameters and covariates. Here, we demonstrate how this complex selection task could benefit from sup...
Journal of pharmacokinetics and pharmacodynamics
Mar 2, 2021
Quantitative systems pharmacology models are often highly complex and not amenable to further simulation and/or estimation analyses. Model-order reduction can be used to derive a mechanistically sound yet simpler model of the desired input-output rel...
Journal of pharmacokinetics and pharmacodynamics
Oct 26, 2020
Deep learning is the fastest growing field in artificial intelligence and has led to many transformative innovations in various domains. However, lack of interpretability sometimes hinders its application in hypothesis-driven domains such as biology ...